Persones / Equip Humà

Rubén Cereijo Téllez

Buscador de publicacions

Publicacions

  • Sánchez-Infantes D, Cereijo R, Sebastiani G, Pérez-Cruz M, Villarroya-Gombau F and Ibañez-Toda L.

    Nerve Growth Factor Levels in Term Human Infants: Relationship to Prenatal Growth and Early Postnatal Feeding

    International Journal of Endocrinology . 2018: 7562702-7562702. Nº de cites: 9

    [doi:10.1155/2018/7562702]

  • Quesada T, Cereijo R, Turatsinze JV, Planavila A, Cairo M, Gavaldà-Navarro A, Peyrou M, Moure R, Iglesias R, Giralt M, Eizirik DL and Villarroya-Gombau F.

    The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes.

    NATURE COMMUNICATIONS . 7: 13479-13479. Nº de cites: 193

    [doi:10.1038/ncomms13479]

  • Cairo M, Villarroya-Terrade J, Cereijo R, Campderrós L, Giralt M and Villarroya-Gombau F.

    Thermogenic activation represses autophagy in brown adipose tissue.

    INTERNATIONAL JOURNAL OF OBESITY . 40(10): 1591-1599. Nº de cites: 45

    [doi:10.1038/ijo.2016.115]

  • Giralt M, Cereijo R and Villarroya-Gombau F.

    Adipokines and the Endocrine Role of Adipose Tissues.

    Handbook of Experimental Pharmacology . 233: 265-282. Nº de cites: 66

    [doi:10.1007/164_2015_6]

  • Cereijo R, Villarroya-Terrade J and Villarroya-Gombau F.

    Non-sympathetic control of brown adipose tissue.

    International journal of obesity supplements . 5(Suppl 1): .

    [doi:10.1038/ijosup.2015.10]

  • Cereijo R, Giralt M and Villarroya-Gombau F.

    Thermogenic brown and beige/brite adipogenesis in humans.

    ANNALS OF MEDICINE . 47(2): 169-177. Nº de cites: 69

    [doi:10.3109/07853890.2014.952328]

  • Hondares E, Gallego-Escuredo JM, Flachs P, Frontini A, Cereijo R, Goday A, Perugini J, Kopecky P, Giralt M, Cinti S, Kopecky J and Villarroya-Gombau F.

    Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue.

    METABOLISM-CLINICAL AND EXPERIMENTAL . 63(3): 312-317. Nº de cites: 73

    [doi:10.1016/j.metabol.2013.11.014]

  • Quesada T, Mestres-Arenas A, Domingo P, Prieto P, Mur I, Hidalgo Pérez JA, Guimarães MP, Villarroya-Terrade J, Gutiérrez MDM, Mateo MG, Domingo JC, Planavila A, Villarroya-Gombau F, Giralt M and Cereijo R.

    Reduced circulating levels of CXCL14 are associated with cardiovascular damage in people living with HIV.

    EUR J PHARMACOL . 1003: 177996-177996.

    [doi:10.1016/j.ejphar.2025.177996]